The IPO Buzz: Oura & Accelevation Set to Ring Out September
Oura is creating some buzz to ring out September. It’s known for the Oura Ring, which it calls “the world’s smallest smart ring.” Its software provides users with data on how their daily habits – diet, exercise, sleep and other metrics – affect their health.
“It’s an always-on health intelligence platform on your finger,” Oura said in the prospectus. “Oura was built to give the body a voice—translating physiological signals across sleep, activity, readiness, stress, heart health, metabolic health, and women’s health into more than 50 metrics and predictive insights.”
Oura (OURA Proposed) is a big deal – no pun intended. Oura’s IPO consists of 50 million shares at a price range of $40.00 to $44.00 to raise $2.1 billion – if priced at the $42.00 mid-point of its range. Of the 50 million shares in the IPO, Oura is offering 13.5 million shares while the selling stockholders are offering 36.5 million shares. Oura will not receive any proceeds from the sale of the selling stockholders’ shares.
Oura intends to use $526.4 million of its net proceeds from the IPO to satisfy its anticipated tax withholding and remittance obligations related to the RSU Net Settlement, the prospectus said.
At mid-point pricing, Oura would have a market cap of $13.48 billion.
Oura, founded in 2013 in Finland, is based in San Francisco.
Oura’s IPO is one of just two sizable deals on this week’s short IPO Calendar. The other deal is Accelevation Holdings (ACCV Proposed), the $660 million IPO for a company that produces power distribution and infrastructure products for AI data centers.
At mid-point pricing, Accelevation would have a market cap of $4.92 billion.
Accelevation is based in Miamisburg, Ohio, about 11 miles southwest of Dayton.
Accelevation’s IPO consists of 30 million shares at a price range of $20.00 to $24.00 to raise $660 million, if priced at the $22.00 mid-point of its range. Of the 30 million shares in Accelevation’s IPO, the company is offering 8.64 million shares and selling stockholders are offering 21.36 million shares.
Accelevation intends to use its proceeds to pay off $180 million of debt, the prospectus said.
Oura & Robinhood
Robinhood is making its debut as an IPO underwriter with Oura’s IPO, according to The Wall Street Journal. Robinhood is the co-manager.
Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Co. and Jefferies are leading the joint book-running team. BofA Securities, Barclays and Wells Fargo Securities are also joint book-runners in a line-up of 17 investment banks.
As of June 30, 2026, Oura served 5 million paid members worldwide – doubling its paid membership from the year-ago period, according to the prospectus.
Oura is profitable: Net income of $59 million on revenue of $1.43 billion for the 12 months that ended on June 30, 2026.
Accelevation & AI
Accelevation is going public after a year of huge growth driven by the AI data center trend. The company’s revenue surged to $437.5 million in the first six months of 2026 – up from $158.6 million in the year-ago period, according to the prospectus.
Accelevation’s clients include large data center operators, cloud providers and hyperscalers.
Accelevation’s name comes from its goal – “Accelerate. Innovation” – according to the founders’ letter in the prospectus from Michael and Shawn Rubiera. (The Rubieras are married.)
Accelevation is profitable: Net income of $21.75 million on revenue of $447.8 million for the year that ended on Dec. 31, 2025.
Stay tuned.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opin
Source: https://www.iposcoop.com/the-ipo-buzz-oura-accelevation-set-to-ring-out-september/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

